gynecology-breast-pathology-2019-keynote

7 / 8

June 28-29, 2019 | Oslo, Norway
Page 30
Journal of Medical and Health Sciences | ISSN : 2319-9865
Joint Event
Volume 08 Breast Pathology & Cancer, Gynecology & Obstetrics Pathology, Palliativecare & Gerontology 2019
Breast Pathology & Cancer Palliativecare & Gerontology Gynecology and Obstetrics Pathology
Nam-Sun Paik, RRJMHS 2019, Volume 08
Current status of Korean breast cancer and new
technology of oncoplastic surgery
Breast cancer is the most common cancer among Korean women, and
still shows annual 6.1% increasing. Common causes of breast cancer
includes first birth at late age, early menarche and late menopause, hormone
replacement therapy, high fat and high calorie diet (BMI↑), alcohol abuse,
lowphysical activity and genetic factors (24,000) inKorea, 2017.The survival
rate of breast cancer patients in Korea was much improved with early
detectionwithevery twoyearnational screeningprogramandnewtreatment
modalities which includes chemotherapy, radiotherapy, immunotherapy,
hormonal therapy, target therapy and multimodality therapy including
precision medicine. The five year and 10-year survival was 91.2% and 84.8%
respectively. So breast cancer specialists started to consider about patients’
quality of life and developed new surgical technique (oncoplastic surgery)
without change of recurrence and survival rates. Breast conserving surgery
(BCS) has showed gradually increasing tendency in Korea, currently about
70%, whichmay be preferable tomastectomy in terms of psychologically and
cosmetically. Recently in Korea, we have much considered for oncoplastic
surgery. The principles of oncoplastic surgery of the breast are based on
complete removal of breast cancer with minimal scarring and producing
optimal breast shape and size. It includes careful preoperative planning as
part of a multidisciplinary approach and a surgical plan that will result in
optimal cancer management and the best possible aesthetic outcome. In
some cases, patients were treated with neoadjuvant chemotherapy with or
without target therapy for good results. Incidence of breast cancer increases
according to improvement of economic status and women’s environmental
factors in Korea. So breast cancer specialists should consider not only
recurrence and survival rate but also QOL with BCS or oncoplastic surgery
Biography
Nam-Sun Paik was graduated from School of Medicine, Seoul National University in 1973.
Currently, he is the Director of Ewha Womens University Cancer Center for Women, Seoul, Korea.
He was the President of Konkuk University Medical Center (2009-2011); Asian Breast Cancer
Society (2006-2008); Korean Breast Cancer Society (2001-2003); and the 3rd Asian Breast Cancer
Society Congress (2000-2001). He was selected as one of the top 100 Health Professional as of
Breast and Stomach Surgical Oncologist, International Biographical center of Cambridge, England
(2006). He was also selected as a Man of the Year, International Biographical center of Cambridge,
England (2001). In 1986, he started BCS in Korea.
Nam-Sun Paik
Ewha Womans Cancer Center
Hospital for Women, South Korea